Global law firm White & Case LLP has advised Nordic Capital Fund IX (Nordic Capital) on the acquisition of Prospitalia GmbH (Prospitalia), a leading healthcare-spend management and technology-enabled clinical solutions company for acute, post-acute and other healthcare service providers and vendors, from Five Arrows Principal Investments.
The parties have agreed not to disclose financial details.
Nordic Capital is a leading healthcare investor. The Prospitalia acquisition is the third healthcare investment by Nordic Capital’s latest fund, Fund IX, and builds on its leading healthcare franchise in Europe. Since inception, Nordic Capital Funds has invested in more than 25 healthcare platforms in Europe and the USA.
Prospitalia, headquartered in Ulm, Germany, has almost 200 employees and serves more than 3,000 customers in Germany, the UK, the Netherlands and Australia, with an aggregated managed spend of €2.4 billion.
The White & Case team which advised on the transaction was led by partner Stefan Koch (Frankfurt) and included partner Hendrik Roehricht and associates Tomislav Vrabec, Hugo Schwarz Leite, Marco Stephan and Paul Kohlhaas (all Frankfurt), partners Bodo Bender, Thomas Flatten (both Frankfurt), Axel Schulz (Brussels) and Markus Mette (Hamburg), counsel Katrin Ruebsamen (Berlin), local partners Ingrid Wijnmalen (Frankfurt) and Lars Petersen (Hamburg) and associates Sebastian Brenner (Frankfurt), Sebastian Stuetze, Stefan Haiplik and Julia Cornelius (all Hamburg).
For more information please speak to your local media contact.